Today, one of the stock in my portfolio - C&O Pharm announced the general offer by Shionogi & Co. This shows that although the market has so far ignored the good china company, there are people recognise the value. First, it was Hsu Fu Chi, offer by Nestle. Now, it is Shionogi & Co offer for C&O Pharm. Number of good companies reducing. Hsu Fu Chi has a good brand name, wide distribution network and low valuation compare to HK peers. It naturally attract company that like to grow in China faster. The same applies to C&O Pharm. Although the result was disappointing, the distribution network is something hard to ignore. Going by this rate, all the good S chip would be taken private, left with those which offer little growth. I think my next forte will be branch out to HK market in order to gain access to China ......